CA2014662C - Anti-virals - Google Patents

Anti-virals Download PDF

Info

Publication number
CA2014662C
CA2014662C CA002014662A CA2014662A CA2014662C CA 2014662 C CA2014662 C CA 2014662C CA 002014662 A CA002014662 A CA 002014662A CA 2014662 A CA2014662 A CA 2014662A CA 2014662 C CA2014662 C CA 2014662C
Authority
CA
Canada
Prior art keywords
medicament
fatty acyl
virals
derivatives
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002014662A
Other languages
English (en)
French (fr)
Other versions
CA2014662A1 (en
Inventor
David F. Horrobin
John C. M. Stewart
Michael D. Winther
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
American Regent Inc
Original Assignee
Efamol Holdings PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898908646A external-priority patent/GB8908646D0/en
Priority claimed from GB898921266A external-priority patent/GB8921266D0/en
Application filed by Efamol Holdings PLC filed Critical Efamol Holdings PLC
Publication of CA2014662A1 publication Critical patent/CA2014662A1/en
Application granted granted Critical
Publication of CA2014662C publication Critical patent/CA2014662C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CA002014662A 1989-04-17 1990-04-17 Anti-virals Expired - Lifetime CA2014662C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB89/08646.6 1989-04-17
GB898908646A GB8908646D0 (en) 1989-04-17 1989-04-17 Anti-viral agents
GB89/21266.6 1989-09-20
GB898921266A GB8921266D0 (en) 1989-09-20 1989-09-20 Anti-viral agents

Publications (2)

Publication Number Publication Date
CA2014662A1 CA2014662A1 (en) 1990-10-17
CA2014662C true CA2014662C (en) 2002-09-17

Family

ID=26295232

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002014662A Expired - Lifetime CA2014662C (en) 1989-04-17 1990-04-17 Anti-virals

Country Status (16)

Country Link
US (2) US5216142A (ja)
EP (2) EP0693498A1 (ja)
JP (1) JP2952505B2 (ja)
KR (1) KR100188616B1 (ja)
AT (1) ATE155142T1 (ja)
AU (1) AU637362B2 (ja)
CA (1) CA2014662C (ja)
DE (1) DE69031007T2 (ja)
DK (1) DK0393920T3 (ja)
ES (1) ES2108686T3 (ja)
FI (1) FI901903A0 (ja)
GR (1) GR3024835T3 (ja)
HK (1) HK1001003A1 (ja)
IE (1) IE980216A1 (ja)
NZ (1) NZ233297A (ja)
TW (1) TW215417B (ja)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107499A (en) * 1988-02-26 2000-08-22 Neuromedica, Inc. Dopamine analog amide
US5216142A (en) * 1989-04-17 1993-06-01 Efamol Holdings Plc Anti-virals
EP0604409B1 (en) * 1990-01-11 2004-07-14 Isis Pharmaceuticals, Inc. Oligonucleotide analogs for detecting and modulating rna activity and gene expression
US5459255A (en) * 1990-01-11 1995-10-17 Isis Pharmaceuticals, Inc. N-2 substituted purines
US6262241B1 (en) * 1990-08-13 2001-07-17 Isis Pharmaceuticals, Inc. Compound for detecting and modulating RNA activity and gene expression
GB2260319B (en) * 1991-10-07 1995-12-06 Norsk Hydro As Acyl derivatives of nucleosides and nucleoside analogues having anti-viral activity
GB9307043D0 (en) * 1993-04-05 1993-05-26 Norsk Hydro As Chemical compounds
MY118354A (en) 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
USRE40546E1 (en) * 1996-05-01 2008-10-21 Scarista, Ltd. 1,3-Propane diol esters and ethers and methods for their use in drug delivery
WO1996034858A1 (en) * 1995-05-01 1996-11-07 Scotia Holdings Plc Nicotinic acid esters and pharmaceutical compositions containing them
US5639460A (en) * 1995-06-07 1997-06-17 Raymond; Hal C. Aqueous plant extract having antiviral activity
US5840711A (en) * 1995-06-21 1998-11-24 University Of Kentucky Research Foundation Compositions containing lithium inorganic salts and anti-viral drugs and method of treating viral infections such as acquired immunodeficiency syndrome
US6703394B2 (en) * 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US5869493A (en) * 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6673784B1 (en) * 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
US6054591A (en) * 1996-03-28 2000-04-25 Shionogi & Co., Ltd. Lymph-absorbable aryl substituted imidazole derivatives
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US6576636B2 (en) * 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
JP2001524486A (ja) * 1997-11-25 2001-12-04 プロタルガ,インコーポレーテッド ヌクレオシド類似成分組成物およびその使用
US5955459A (en) * 1997-11-26 1999-09-21 Neuromedica, Inc. Fatty acid-antipsychotic compositions and uses thereof
US5977174A (en) * 1997-11-26 1999-11-02 Neuromedica, Inc. Cholinergic compositions and uses thereof
US6153653A (en) * 1997-11-26 2000-11-28 Protarga, Inc. Choline compositions and uses thereof
US6197764B1 (en) 1997-11-26 2001-03-06 Protarga, Inc. Clozapine compositions and uses thereof
US6225444B1 (en) 1998-02-10 2001-05-01 Protarga, Inc. Neuroprotective peptides and uses thereof
WO2000016625A1 (en) * 1998-09-23 2000-03-30 University Of Kentucky Research Foundation Antiviral drug compositions containing lithium inorganic salts
US7235583B1 (en) * 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US6653318B1 (en) 1999-07-21 2003-11-25 Yale University 5-(E)-Bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
ES2387562T3 (es) * 2001-03-23 2012-09-26 Luitpold Pharmaceuticals, Inc. Conjugados alcohol graso-medicamento
AU2002303164A1 (en) * 2001-03-23 2002-10-08 Protarga, Inc. Fatty amine drug conjugates
US20060122174A1 (en) * 2001-09-21 2006-06-08 Henderson Morley Research & Development Limited Antiviral treatment
CA2421026C (en) * 2001-10-16 2005-02-15 Avanir Pharmaceuticals Viral inhibition by n-docosanol
TWI332507B (en) * 2002-11-19 2010-11-01 Hoffmann La Roche Antiviral nucleoside derivatives
WO2004052905A2 (en) * 2002-12-10 2004-06-24 F. Hoffmann-La Roche Ag Antiviral nucleoside derivatives
US7417037B2 (en) * 2004-01-20 2008-08-26 The Board Of Regents Of The University Of Oklahoma Compositions and methods of treatment for inflammatory diseases
NO324263B1 (no) 2005-12-08 2007-09-17 Clavis Pharma Asa Kjemiske forbindelser, anvendelse derav ved behandling av kreft, samt farmasoytiske preparater som omfatter slike forbindelser
US20090111774A1 (en) * 2007-06-01 2009-04-30 Luitpold Pharmaceuticals, Inc. Pmea lipid conjugates
CN101835374B (zh) 2007-07-09 2014-08-27 东弗吉尼亚医学院 具有抗病毒和抗微生物性质的取代的核苷衍生物
MX2010003002A (es) 2007-09-26 2010-07-05 Sinai School Medicine Analogos de azacitidina y sus usos.
US10463684B2 (en) 2014-01-29 2019-11-05 Board Of Regents, The Uneversety Of Texas System Nucleobase analogue derivatives and their applications

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2354288C2 (de) * 1973-10-30 1976-01-02 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von Aminophenylalkyläthern
JPS5126883A (en) * 1974-08-22 1976-03-05 Asahi Chemical Ind N44 ashiru shichijinno seiho
JPS5132573A (en) * 1974-09-11 1976-03-19 Asahi Chemical Ind Nn ashiruarabinonukureoshido no seizohoho
US4340728A (en) * 1979-11-28 1982-07-20 Fuji Kagaku Kogyo Kabushiki Kaisha Nucleoside derivatives and process for preparing same
DE3100478A1 (de) * 1981-01-09 1982-08-12 Dr. Thilo & Co GmbH, 8021 Sauerlach 5'ester von pyrimidinnucleosiden mit antiviraler wirksamkeit, verfahren zur herstellung und daraus hergestellte arzneimittel
JPS5813394A (ja) * 1981-07-17 1983-01-25 Ajinomoto Co Inc 1−β−D−リボフラノシル−4,5−置換イミダゾ−ルの製造法
EP0082668A1 (en) * 1981-12-18 1983-06-29 Beecham Group Plc 5-(2-Halogenovinyl)-2'-deoxyuridine derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in treating viral infections
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
US4612314A (en) * 1982-12-22 1986-09-16 Syntex (U.S.A.) Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
IL72173A0 (en) * 1983-06-24 1984-10-31 Merck & Co Inc Guanine derivatives,their preparation and pharmaceutical compositions containing them
JPS6144897A (ja) * 1984-08-10 1986-03-04 Terumo Corp 5−フルオロウラシル誘導体およびこれを含有する医薬製剤
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
CA1285935C (en) * 1985-03-16 1991-07-09 Janet Lister Rideout Therapeutic nucleosides
FR2580283B1 (fr) * 1985-04-15 1989-11-24 Toyo Jozo Kk Nouveau conjugue nucleoside-phospholipide
GB2181128A (en) * 1985-09-17 1987-04-15 Wellcome Found 3'-azidonucleosides
EP0262876B1 (en) * 1986-09-27 1992-04-29 Toyo Jozo Kabushiki Kaisha Nucleoside-phospholipid conjugate
DE3856557T2 (de) * 1987-10-28 2004-06-03 Wellstat Therapeutics Corp. Acyldeoxyribonukleosid-Derivate und Verwendungen davon
DE3883374T2 (de) * 1987-10-28 1993-12-09 Pro Neuron Inc Acylatiertes uridin und cytidin und deren verwendungen.
US5216142A (en) * 1989-04-17 1993-06-01 Efamol Holdings Plc Anti-virals

Also Published As

Publication number Publication date
US5216142A (en) 1993-06-01
JPH02304084A (ja) 1990-12-17
KR100188616B1 (ko) 1999-06-01
DE69031007T2 (de) 1997-12-04
AU637362B2 (en) 1993-05-27
JP2952505B2 (ja) 1999-09-27
KR900015742A (ko) 1990-11-10
TW215417B (ja) 1993-11-01
EP0393920A2 (en) 1990-10-24
US5276020A (en) 1994-01-04
EP0693498A1 (en) 1996-01-24
ES2108686T3 (es) 1998-01-01
EP0393920A3 (en) 1991-07-03
ATE155142T1 (de) 1997-07-15
EP0393920B1 (en) 1997-07-09
IE980216A1 (en) 2000-02-23
AU5329090A (en) 1990-10-18
CA2014662A1 (en) 1990-10-17
HK1001003A1 (en) 1998-05-15
NZ233297A (en) 1997-07-27
DK0393920T3 (da) 1997-09-22
DE69031007D1 (de) 1997-08-14
GR3024835T3 (en) 1998-01-30
FI901903A0 (fi) 1990-04-12

Similar Documents

Publication Publication Date Title
CA2014662C (en) Anti-virals
US10344046B2 (en) Nucleotide and oligonucleotide prodrugs
CA1333390C (en) Fluorinated nucleosides and process for treating retrovirus infections therewith
RU2139884C1 (ru) Моноэфирные соединения, фармацевтическая композиция
US5073546A (en) Lipophilic salts of S-adenosyl-L-methionine (SAM) with acylated taurine derivatives
US5384310A (en) 2'-fluoro-2-haloarabinoadinosines and their pharmaceutical compositions
US5496935A (en) 2',3'-dideoxynucleoside pyrimidine compounds and carbocyclic analogs
EP0642525B1 (en) Nucleosides being O-acylated with a mono-unsaturated omega-9 C18 or C20 fatty acid
Yoshihiko et al. 3′, 5′-diesters of 5-fluoro-2′-deoxyuridine: synthesis and biological activity
JPH04226999A (ja) 抗ウイルス剤
McGuigan et al. Kinase bypass: a new strategy for anti-HIV drug design
CA2244378A1 (en) Modified benzimidazole nucleosides as antiviral agents
US4868162A (en) Antiviral agent
KR0141684B1 (ko) 2`,5`-올리고 아데닐레이트 유도체의 치료학적 이용
CA1062704A (en) 9-(3-O-ACYL-.beta.-D-ARABINOFURANOSYL) ADENINE COMPOUNDS, 9-(2,3-DI-O-ACYL-.beta.-D-ARABINOFURANOSYL) ADENINE COMPOUNDS, AND METHOD FOR THEIR PRODUCTION
US4265886A (en) Spiroketalins and their applications
Baker et al. Synthesis and evaluation of a series of 2'-O-acyl derivatives of 9-. beta.-D-arabinofuranosyladenine as antiherpes agents
US4104461A (en) 2,2'-Anhydro-β-D-arabinofuranosyl-5-fluorocytosine
KR860001867B1 (ko) 2'-데옥시-5-치환 우리딘 유도체의 제조방법
EP0095292A1 (en) 5-(2-halogenovinyl)-2'-deoxyuridine derivatives, processes for their preparation, pharmaceutical compositions containing them, and their use in treating viral infections"
DD290808A5 (de) Verfahren zur herstellung eines mittels fuer die behandlung oder prophylaxe von durch retroviren verursachte infektionen bei mensch und tier

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry